Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 287
Filter
Add more filters

Publication year range
1.
Am J Otolaryngol ; 45(1): 104099, 2024.
Article in English | MEDLINE | ID: mdl-37948820

ABSTRACT

The pathophysiology and the proper treatment of idiopathic sudden sensorineural hearing loss (ISSNHL) are an ongoing subject of debate. Locally or systemic administered corticosteroids are the most accepted drugs of treatment in reference to ISSNHL (idiopathic sudden sensorineural hearing loss), however, no strong evidence nor guidelines regarding their effectiveness yet exists. In our prospective, randomized, controlled trial 78 participants were enrolled. Patients were randomly assigned based on the day of admission to two groups according to treatment: group SS (n = 43) received intravenous systemic methylprednisolone alone, and group CT (n = 35) received intratympanic dexamethasone + systemic methylprednisolone. The primary outcome was to compare the hearing outcomes between the treatment groups based on different, widely accepted categories (Siegel, Kanzaki, modified Siegel and PTA4 gain). In consideration of the secondary outcome, we examined the effect of the various risk factors on the hearing improvement. No differences were detected regarding hearing improvement between the two groups, based on any criteria [Siegel's criteria (p = 0.604); Kanzaki's criteria (p = 0.720); modified Siegel's criteria (p = 0.524) and PTA 4 gain (p = 0.569)]. However, several clinical factors such as vertigo (p = 0.039), or cardiovascular comorbidity (p = 0.02) and the severity of initial hearing loss (p = 0.033) were found to bear a significant impact upon the hearing outcome. To the best of our knowledge, this is the first randomized controlled trial comparing high dose systemic and combination corticosteroid therapy in ISSNHL patients. Our findings suggest coexisting cardiovascular comorbidity, vertigo and severity of the initial hearing loss may bear a significantly higher impact upon hearing improvement, than the additional intratympanic steroid administration. The presented trial was registered in the European Union Drug Regulating Authorities Clinical Trials Database (name: Combinated systemic and intratympanic steroid therapy in idiopathic sudden sensorineural hearing loss, No.: 2017-000658-20) and with the ethical approval of The National Institute of Pharmacy and Nutrition (OGYÉI) (protocol No.: 7621, on 2017.02.16.).


Subject(s)
Hearing Loss, Sensorineural , Hearing Loss, Sudden , Humans , Prospective Studies , Treatment Outcome , Methylprednisolone , Glucocorticoids , Hearing Loss, Sudden/diagnosis , Hearing Loss, Sudden/drug therapy , Hearing Loss, Sudden/complications , Hearing Loss, Sensorineural/diagnosis , Hearing Loss, Sensorineural/drug therapy , Hearing Loss, Sensorineural/etiology , Adrenal Cortex Hormones/therapeutic use , Risk Factors , Vertigo/drug therapy , Injection, Intratympanic , Dexamethasone
2.
Pathologe ; 42(2): 172-182, 2021 Mar.
Article in German | MEDLINE | ID: mdl-33646363

ABSTRACT

The health effects of coronavirus disease 2019 (COVID-19) caused by the infection of SARS-CoV­2 (severe acute respiratory syndrome coronavirus 2) are becoming increasingly clear as the pandemic spreads. In addition to the lungs, other organs are also affected, which can significantly influence morbidity and mortality. In particular, neurological symptoms involving the central nervous system can lead to acute or long-term consequences. The mechanisms of this neuropathogenesis of SARS-CoV­2 infection and its relation to acute and chronic neurological symptoms are the subject of current studies investigating a potential direct and indirect viral infection of the nervous system. The following review summarizes the current status of neuropathological manifestations, molecular pathogenesis, possible infection pathways in the nervous system, and systemic effects. In addition, an overview of the Germany-wide CNS-COVID19 registry and collaborations is presented, which should contribute to a better understanding of the neurological symptoms of COVID-19.


Subject(s)
COVID-19 , Germany , Humans , Pandemics , Peripheral Nervous System , SARS-CoV-2
3.
Pediatr Transplant ; 21(2)2017 Mar.
Article in English | MEDLINE | ID: mdl-27957786

ABSTRACT

Biliary atresia (BA) is the most common indication for LT in children. We investigated whether this diagnosis per se, compared to other chronic liver diseases (OCLD), had an influence on patient survival. Data from 421 Scandinavian children, 194 with BA and 227 with OCLD, listed for LT between 1990 and 2010 were analyzed. The intention-to-treat survival and influencing risk factors were studied. Patients with BA had higher risk of death after listing than patients with OCLD. The youngest (<1 year) and smallest (<10 kg) children with the highest bilirubin (>510 µmol/L), highest INR (>1.6), and highest PELD score (>20) listed during 1990s had the worst outcome. Given the same PELD score, patients with BA had higher risk of death than patients with OCLD. For adolescents, low weight/BMI was the only prognostic marker. Impaired intention-to-treat survival in patients with BA was mainly explained by more advanced liver disease in younger ages and higher proportion of young children in the BA group rather than diagnosis per se. PELD score predicted death, but seemed to underestimate the severity of liver disease in patients with BA. Poor nutritional status and severe cholestasis had negative impact on survival, supporting the "sickest children first" allocation policy and correction of malnutrition before surgery.


Subject(s)
Biliary Atresia/mortality , Biliary Atresia/surgery , Liver Failure/mortality , Liver Failure/surgery , Liver Transplantation , Adolescent , Body Mass Index , Child , Child, Preschool , Female , Graft Survival , Humans , Infant , Infant, Newborn , Intention to Treat Analysis , International Normalized Ratio , Male , Multivariate Analysis , Nutritional Status , Prognosis , Prospective Studies , Registries , Risk Factors , Scandinavian and Nordic Countries , Time-to-Treatment , Treatment Outcome
4.
Am J Transplant ; 16(3): 1021-30, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26523372

ABSTRACT

Clinical hepatocyte transplantation is hampered by low engraftment rates and gradual loss of function resulting in incomplete correction of the underlying disease. Preconditioning with partial hepatectomy improves engraftment in animal studies. Our aim was to study safety and efficacy of partial hepatectomy preconditioning in clinical hepatocyte transplantation. Two patients with Crigler-Najjar syndrome type I underwent liver resection followed by hepatocyte transplantation. A transient increase of hepatocyte growth factor was seen, suggesting that this procedure provides a regenerative stimulus. Serum bilirubin was decreased by 50%, and presence of bilirubin glucuronides in bile confirmed graft function in both cases; however, graft function was lost due to discontinuation of immunosuppressive therapy in one patient. In the other patient, serum bilirubin gradually increased to pretransplant concentrations after ≈600 days. In both cases, loss of graft function was temporally associated with emergence of human leukocyte antigen donor-specific antibodies (DSAs). In conclusion, partial hepatectomy in combination with hepatocyte transplantation was safe and induced a robust release of hepatocyte growth factor, but its efficacy on hepatocyte engraftment needs to be evaluated with additional studies. To our knowledge, this study provides the first description of de novo DSAs after hepatocyte transplantation associated with graft loss.


Subject(s)
Antibody Formation/immunology , Crigler-Najjar Syndrome/immunology , Graft Rejection/etiology , HLA Antigens/immunology , Hepatectomy/adverse effects , Hepatocytes/transplantation , Liver Transplantation/adverse effects , Tissue Donors , Adolescent , Adult , Child , Crigler-Najjar Syndrome/surgery , Female , Humans , Infant , Male , Postoperative Complications , Prognosis
5.
Clin Rehabil ; 29(2): 196-206, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25142278

ABSTRACT

OBJECTIVE: To explore exercise response in people with Huntington's disease (HD). DESIGN: Experimental observational study with a randomly allocated subgroup before/after interventional study. SETTING: Community. SUBJECTS: People with HD (n=30) and a healthy comparator group (n=20). Thirteen people from the HD group were randomly allocated to an exercise training program. MAIN MEASURES: Heart rate (HR) and perceived exertion on the Borg-CR10 scale (RPE) during a submaximal cycle ergometer exercise test (three minute unloaded and nine minute 65%-75%HRmaximum phase). Expired air and lactate measures were available for 8 people with HD during the exercise. INTERVENTION: A 12 week gym and home walking exercise programme (n=13). RESULTS: People with HD achieved a lower work rate at nine minutes (82±42(0-195) v 107±35(50 -185) Watts (p<0.05)), but higher RPE at both three (3±2(0-7) v 1±1(0-4)) and nine minutes (7±3(1-10) v 5± 2(2-9)) both p<0.01, compared to the healthy group and did not achieve a steady state HR during unloaded cycling. People with HD also demonstrated higher than expected lactate at three 2.5±2.5(1.1-8)mmo.L-1 and nine 3.8±1.9(1.2-6.6)mmo.L-1 minutes and respiratory exchange ratio at three 0.78±0.03 (0.74-0.81) and nine minutes 0.94±0.11(0.81-1.15). After exercise training there were no changes observed in HR or RPE responses during the exercise test. CONCLUSIONS: There was a large variability in the observed metabolic and physiological responses to exercise in people with HD. The observed exercise responses suggest that altered exercise prescription parameters may be required for people with HD and that exercise response and factors' affecting this requires further investigation.


Subject(s)
Exercise Test , Exercise Therapy , Huntington Disease/physiopathology , Huntington Disease/rehabilitation , Adult , Aged , Female , Humans , Male , Middle Aged
6.
J Mater Sci Mater Med ; 26(2): 70, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25631267

ABSTRACT

In vivo insertion experiments are essential to optimize novel neural implants. Our work focuses on the interaction between intact dura mater of rats and as-fabricated single-shaft silicon microprobes realized by deep reactive ion etching. Implantation parameters like penetration force and dimpling through intact dura mater were studied as a function of insertion speed, microprobe cross-section, tip angle and animal age. To reduce tissue resistance, we proposed a unique tip sharpening technique, which was also evaluated in in vivo insertion tests. By doubling the insertion speed (between 1.2 and 10.5 mm/min), an increase of 10-35% in penetration forces was measured. When decreasing the cross-section of the microprobes, penetration forces and dimpling was reduced by as much as 30-50% at constant insertion speeds. Force was noticed to gradually decrease by decreasing tip angles. Measured penetration forces through dura mater were reduced even down to 11±3 mN compared to unsharpened (49±13 mN) probes by utilizing our unique tip sharpening technique, which is very close to exerted penetration force in the case of retracted dura (5±1.5 mN). Our findings imply that age remarkably alters the elasticity of intact dura mater. The decreasing stiffness of dura mater results in a significant rise in penetration force and decrease in dimpling. Our work is the first in vivo comparative study on microelectrode penetration through intact and retracted dura mater.


Subject(s)
Dura Mater/physiology , Microelectrodes , Prosthesis Implantation/methods , Spinal Puncture/instrumentation , Spinal Puncture/methods , Animals , Dura Mater/surgery , Elastic Modulus/physiology , Equipment Design , Equipment Failure Analysis , Pressure , Rats , Rats, Sprague-Dawley , Stress, Mechanical
7.
Z Rheumatol ; 73(2): 175-9, 2014 Mar.
Article in German | MEDLINE | ID: mdl-24306839

ABSTRACT

Pregnancy in women diagnosed with systemic sclerosis generally has a favorable outcome according to most recent studies. Women with systemic sclerosis who wish to become pregnant should achieve low disease activity for at least 6 months prior to conception. Regular follow-up of pregnant scleroderma patients by an interdisciplinary medical team including gynaecologists and rheumatologists is necessary to control disease activity and avoid possible complications. Severe organ involvement, early diffuse systemic sclerosis with rapid onset, and pulmonary hypertension ought to discourage patients from pregnancy, as these situations are at high risk of complications for both mother and fetus during pregnancy.


Subject(s)
Patient Care Management/methods , Pregnancy Complications/diagnosis , Pregnancy Complications/therapy , Scleroderma, Systemic/diagnosis , Scleroderma, Systemic/therapy , Female , Humans , Pregnancy , Risk Assessment
8.
Nat Genet ; 28(2): 119-20, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11381253

ABSTRACT

Chorea-acanthocytosis (CHAC, MIM 200150) is an autosomal recessive neurodegenerative disorder characterized by the gradual onset of hyperkinetic movements and abnormal erythrocyte morphology (acanthocytosis). Neurological findings closely resemble those observed in Huntington disease. We identified a gene in the CHAC critical region and found 16 different mutations in individuals with chorea-acanthocytosis. CHAC encodes an evolutionarily conserved protein that is probably involved in protein sorting.


Subject(s)
Chorea/genetics , Mutation , Proteins/genetics , Saccharomyces cerevisiae Proteins , Alternative Splicing , Animals , Caenorhabditis elegans/genetics , Cell Line , Chromosomes, Human, Pair 6 , Erythrocytes/physiology , Exons , Fungal Proteins/genetics , Gene Expression Regulation , Haplotypes , Humans , Pedigree , Protein Transport , Proteins/metabolism , Sequence Homology, Amino Acid , Transcription, Genetic , Vesicular Transport Proteins
9.
Nat Genet ; 20(3): 233-8, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9806540

ABSTRACT

The progressive familial intrahepatic cholestases (PFIC) are a group of inherited disorders with severe cholestatic liver disease from early infancy. A subgroup characterized by normal serum cholesterol and gamma-glutamyltranspeptidase (gammaGT) levels is genetically heterogeneous with loci on chromosomes 2q (PFIC2) and 18q. The phenotype of the PFIC2-linked group is consistent with defective bile acid transport at the hepatocyte canalicular membrane. The PFIC2 gene has now been identified by mutations in a positional candidate, BSEP, which encodes a liver-specific ATP-binding cassette (ABC) transporter, sister of p-glycoprotein (SPGP). The product of the orthologous rat gene has been shown to be an effective bile acid transporter in vitro. These data provide evidence that SPGP is the human bile salt export pump (BSEP).


Subject(s)
ATP-Binding Cassette Transporters/genetics , Cholestasis, Intrahepatic/genetics , Mutation , ATP Binding Cassette Transporter, Subfamily B, Member 11 , ATP-Binding Cassette Transporters/chemistry , ATP-Binding Cassette Transporters/metabolism , Amino Acid Sequence , Animals , Bile Acids and Salts/metabolism , Cholestasis, Intrahepatic/metabolism , Chromosome Mapping , Chromosomes, Human, Pair 2/genetics , Consanguinity , DNA, Complementary/genetics , Female , Humans , Infant , Liver/metabolism , Male , Molecular Sequence Data , Pedigree , Rats , Sequence Homology, Amino Acid
10.
J Intern Med ; 272(3): 201-23, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22789058

ABSTRACT

Inherited metabolic diseases of the liver are characterized by deficiency of a hepatic enzyme or protein often resulting in life-threatening disease. The remaining liver function is usually normal. For most patients, treatment consists of supportive therapy, and the only curative option is liver transplantation. Hepatocyte transplantation is a promising therapy for patients with inherited metabolic liver diseases, which offers a less invasive and fully reversible approach. Procedure-related complications are rare. Here, we review the experience of hepatocyte transplantation for metabolic liver diseases and discuss the major obstacles that need to be overcome to establish hepatocyte transplantation as a reliable treatment option in the clinic.


Subject(s)
Cell Transplantation/methods , Hepatocytes/cytology , Liver Diseases/therapy , Metabolism, Inborn Errors/therapy , Adaptive Immunity , Animals , Cell Culture Techniques , Cellular Senescence , Cryopreservation , Humans , Immunity, Innate , Immunosuppression Therapy , Tissue Donors , Transplantation Conditioning
11.
Physiol Int ; 2021 Jun 29.
Article in English | MEDLINE | ID: mdl-34224400

ABSTRACT

BACKGROUND: Pathological alterations in nutritional status may develop in Chronic Obstructive Pulmonary Disease (COPD) patients through production of inflammatory cytokines and inadequate diet. OBJECTIVE: The aim of our study was to determine the correlation between nutritional status and quality of life of COPD patients. METHODS: We evaluated the nutritional status of COPD patients of Hungarian National Koranyi Institute for Pulmonology using the Malnutrition Universal Screening Tool (MUST) and bioelectrical impedance analysis (BIA) between January 1 and June 1, 2019. Lung function, physical fitness, and respiratory muscle strength were included in the assessment. RESULTS: Fifty patients (mean age was 66.3 ± 9.6 years) participated in our study. Mean body mass index (BMI) was 26.2 ± 6.1 kg/m2 and mean fat-free mass index (FFMI) was 16.8 ± 2.4 kg/m2. Overweight patients had better lung function values (FEV1ref%: 46.3 ± 15.2) than normal (FEV1ref%: 45.1 ± 20.9) and underweight patients (FEV1ref%: 43.8 ± 16.0). The Modified Medical Research Council Dyspnea Scale (mMRC) was significantly associated with various parameters; strongest correlation was found with FFMI (r = -0.537, P < 0.001), skeletal muscle mass index (SMMI) (r = -0.530, P < 0.001), and 6-minute walking distance (6MWD) (r = -0.481, P < 0.001). CONCLUSIONS: Our results indicate that malnourished COPD patients may have reduced lung function and lower quality of life compared to normal weight patients. Thus, our findings suggest that nutritional therapy be included in the treatment of COPD patients combined with nutritional risk screening and BIA during the follow-up.

12.
J Theor Biol ; 264(2): 301-11, 2010 May 21.
Article in English | MEDLINE | ID: mdl-20149800

ABSTRACT

It seems obvious that as the benefits of cooperation increase, the share of cooperators in the population should also increase. It is well known that positive assortment between cooperative types, for instance in spatially structured populations, provide better conditions for the evolution of cooperation than complete mixing. This study demonstrates that, assuming positive assortment, under most conditions higher cooperation benefits also increase the share of cooperators. On the other hand, under a specified range of payoff values, when at least two payoff parameters are modified, the reverse is true. The conditions for this paradox are determined for two-person social dilemmas: the Prisoner's Dilemma, the Hawks and Doves game, and the Stag Hunt game, assuming global selection and positive assortment.


Subject(s)
Cooperative Behavior , Game Theory , Models, Theoretical , Altruism , Biological Evolution , Competitive Behavior , Computer Simulation , Humans , Population Dynamics , Social Behavior
13.
J Cell Biol ; 48(2): 235-47, 1971 Feb.
Article in English | MEDLINE | ID: mdl-5543397

ABSTRACT

The 5 day chick embryo liver cell still lacks many of the ultrastructural features of the adult liver cell. During organ culture on rafts over Eagle's medium, it develops electron-opaque mitochondria with granules, biliary microvilli, and compact Golgi complexes containing what appears to be secretory material. Rough ER proliferates and free ribosomes become bound to membrane. Thus, the 5 day cell, exposed only to simple nutrients (glucose, amino acids, vitamins) develops the general appearance of the adult liver cell except for the continued absence of smooth ER and glycogen. The significance of this incomplete differentiation and the factors controlling development are discussed in the light of accompanying metabolic changes.


Subject(s)
Liver/embryology , Age Factors , Animals , Cell Differentiation , Chick Embryo , Culture Media , Liver/cytology
14.
J Cell Biol ; 55(2): 448-56, 1972 Nov.
Article in English | MEDLINE | ID: mdl-5076783

ABSTRACT

Uridine diphosphate (UDP) glucuronyltransferase activity in chick liver rises at hatching from near zero to adult levels. This rise will occur prematurely in embryo liver during organ culture. Increase in enzyme activity during organ culture differs with embryo age: in liver from 11-day old embryos it ceases at adult values; in liver from 5-day old embryos it continues to much higher-than-adult levels. Phenobarbital added to culture medium accelerates these rises in enzyme activity and elevates the plateau reached in 11-day embryo liver to that observed in 5-day embryo liver. Kinetic analysis of the changes in enzyme activity induced by phenobarbital during culture suggests that the regulatory mechanisms for enzyme activity are different in 5- and 11-day embryo liver and that these differences reflect developmental changes occurring in ovo.


Subject(s)
Hexosyltransferases/biosynthesis , Liver/enzymology , Age Factors , Animals , Carbon Isotopes , Cell Fractionation , Chick Embryo , Culture Media , Cycloheximide/pharmacology , Hexosyltransferases/analysis , Kinetics , Leucine/metabolism , Liver/drug effects , Liver/embryology , Methods , Organ Culture Techniques , Phenobarbital/pharmacology , Protein Biosynthesis , RNA/biosynthesis , Tritium , Uridine/metabolism
15.
J Cell Biol ; 70(2 pt 1): 319-25, 1976 Aug.
Article in English | MEDLINE | ID: mdl-820699

ABSTRACT

UDP-Glucuronyltransferase (GT) activity increases in chick embryo liver during culture from zero to a steady-state level at or above adult values. The GT activity (o-aminophenol as acceptor) is located entirely in the membranes of the endoplasmic reticulum (ER) and the question arises whether ER increases along with GT. Earlier work showed that the synthesis and degradation rates of GT can be varied in culture over wide ranges by choosing embryo livers of different ages and both phenobarbital. In the present study we measured the GT activities and the concentrations of ER (using stereologic methods) in 5- and 11-day embryo liver during culture with and without phenobarbital. We found that GT and ER always increased in a constant ratio of 2.2 X 10(-9) U of GR activity per square micrometer of membrane, suggesting that the synthesis and degradation of GT are coupled to the synthesis and degradation of ER. A general structure for ER is proposed to explain this finding.


Subject(s)
Endoplasmic Reticulum , Glucuronosyltransferase/metabolism , Hexosyltransferases/metabolism , Liver/ultrastructure , Phenobarbital/pharmacology , Animals , Cell Division , Chick Embryo , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/enzymology , Glucuronosyltransferase/biosynthesis , Liver/enzymology , Morphogenesis/drug effects
16.
Brain ; 131(Pt 10): 2632-46, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18757886

ABSTRACT

The largest kindred with inherited prion disease P102L, historically Gerstmann-Sträussler-Scheinker syndrome, originates from central England, with émigrés now resident in various parts of the English-speaking world. We have collected data from 84 patients in the large UK kindred and numerous small unrelated pedigrees to investigate phenotypic heterogeneity and modifying factors. This collection represents by far the largest series of P102L patients so far reported. Microsatellite and genealogical analyses of eight separate European kindreds support multiple distinct mutational events at a cytosine-phosphate diester-guanidine dinucleotide mutation hot spot. All of the smaller P102L kindreds were linked to polymorphic human prion protein gene codon 129M and were not connected by genealogy or microsatellite haplotype background to the large kindred or each other. While many present with classical Gerstmann-Sträussler-Scheinker syndrome, a slowly progressive cerebellar ataxia with later onset cognitive impairment, there is remarkable heterogeneity. A subset of patients present with prominent cognitive and psychiatric features and some have met diagnostic criteria for sporadic Creutzfeldt-Jakob disease. We show that polymorphic human prion protein gene codon 129 modifies age at onset: the earliest eight clinical onsets were all MM homozygotes and overall age at onset was 7 years earlier for MM compared with MV heterozygotes (P = 0.02). Unexpectedly, apolipoprotein E4 carriers have a delayed age of onset by 10 years (P = 0.02). We found a preponderance of female patients compared with males (54 females versus 30 males, P = 0.01), which probably relates to ascertainment bias. However, these modifiers had no impact on a semi-quantitative pathological phenotype in 10 autopsied patients. These data allow an appreciation of the range of clinical phenotype, modern imaging and molecular investigation and should inform genetic counselling of at-risk individuals, with the identification of two genetic modifiers.


Subject(s)
Gerstmann-Straussler-Scheinker Disease/genetics , Point Mutation , Prions/genetics , Adult , Age of Onset , Aged , Brain/pathology , Electrocardiography , Electromyography , England , Europe , Female , Genealogy and Heraldry , Genetic Testing , Gerstmann-Straussler-Scheinker Disease/diagnosis , Haplotypes , Heterozygote , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Pedigree , Phenotype , Tomography, X-Ray Computed
17.
J Chem Phys ; 131(5): 054510, 2009 Aug 07.
Article in English | MEDLINE | ID: mdl-19673577

ABSTRACT

The early stage of molecular excitonics and its quantum-kinetic dynamics in the multiband, bitubular cyanine dye aggregate C(8)O(3) at room temperature are revealed by employing two-dimensional (2D) coherent electronic spectroscopy in the visible spectral region. The sub-20 fs measurements provide a direct look into the details of elementary electronic couplings by spreading spectroscopic transitions into two frequency axes. Correlation spectra of rephasing (k(I) = -k(1) + k(2) + k(3)) and nonrephasing (k(II) = +k(1) - k(2) + k(3)) data in emission (omega(3))-absorption (omega(1)) 2D-frequency space image interband excitons into cross-peak signals and unveil the quantum-dissipative regime of exciton relaxation. Spectral streaking of cross peaks directly reveals interband dephasing and exciton population relaxation on the road to tube-to-tube energy transfer without making recourse to an a priori model. Theory and simulations, based on an effective multilevel scheme and a quantum-dissipative model with experimental pulse envelopes, explain the origin of the cross peaks, reveal the underlying sequences of electronic transitions, recover the streaking patterns of relaxing cross peaks along omega(1), and reconstruct the space-energy pathways of electronic excitation flow.


Subject(s)
Electrons , Energy Transfer , Absorption , Carbocyanines/chemistry , Models, Chemical , Spectrum Analysis , Temperature
18.
AJNR Am J Neuroradiol ; 40(7): 1084-1090, 2019 07.
Article in English | MEDLINE | ID: mdl-31196862

ABSTRACT

Functional MR imaging is being performed with increasing frequency in the typical neuroradiology practice; however, many readers of these studies have only a limited knowledge of the functional anatomy of the brain. This text will delineate the locations, anatomic boundaries, and functions of the cortical regions of the brain most commonly encountered in clinical practice-specifically, the regions involved in movement and language.


Subject(s)
Brain Mapping/methods , Brain/anatomy & histology , Magnetic Resonance Imaging/methods , Female , Humans , Language , Male , Middle Aged , Movement
19.
Eur J Paediatr Neurol ; 23(5): 692-706, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31481303

ABSTRACT

Early onset cerebellar Ataxia (EOAc) comprises a large group of rare heterogeneous disorders. Determination of the underlying etiology can be difficult given the broad differential diagnosis and the complexity of the genotype-phenotype relationships. This may change the diagnostic work-up into a time-consuming, costly and not always rewarding task. In this overview, the Childhood Ataxia and Cerebellar Group of the European Pediatric Neurology Society (CACG-EPNS) presents a diagnostic algorithm for EOAc patients. In seven consecutive steps, the algorithm leads the clinician through the diagnostic process, including EOA identification, application of the Inventory of Non-Ataxic Signs (INAS), consideration of the family history, neuro-imaging, laboratory investigations, genetic testing by array CGH and Next Generation Sequencing (NGS). In children with EOAc, this algorithm is intended to contribute to the diagnostic process and to allow uniform data entry in EOAc databases.


Subject(s)
Algorithms , Decision Support Systems, Clinical , Spinocerebellar Degenerations/diagnosis , Adolescent , Child , Diagnosis, Differential , Female , Humans , Male
20.
AJNR Am J Neuroradiol ; 44(10): 1109-1115, 2023 10.
Article in English | MEDLINE | ID: mdl-37793783

Subject(s)
Neurology , Radiology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL